Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | STAT3 | P40763 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | GLA | P06280 | 2/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | MMP14 | P50281 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MGAM | O43451 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.38 |
| ▸ | CASP6 | P55212 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16401320 | 0.98 | KDM4E (0.46) | KDM4EALDH1A1HPGDGAASTAT3 | |
| Lithium Ion SCHEMBL16401318 | 0.79 | ALDH1A1 (0.39) | KDM4EALDH1A1HPGDGAAMAPT | |
| SCHEMBL11280043 | 0.78 | MAPT (0.43) | KDM4EALDH1A1HPGDGAAMAPT | |
| SCHEMBL22837219 | 0.76 | TLR8 (0.37) | KDM4EALDH1A1HPGDGAASTAT3 | |
| SCHEMBL11275569 | 0.70 | NPSR1 (0.44) | KDM4EALDH1A1HPGDGAAMAPT | |
| SCHEMBL21503919 | 0.69 | KDR (0.50) | KDM4EALDH1A1MAPTLMNAMGAM | |
| SCHEMBL667881 | 0.69 | ALDH1A1 (0.59) | KDM4EALDH1A1HPGDGAASTAT3 | |
| SCHEMBL16401204 | 0.68 | MGAM (0.48) | KDM4EALDH1A1HPGDGAAMAPT | |
| SCHEMBL30382206 | 0.68 | MGAM (0.48) | KDM4EALDH1A1HPGDGAAMAPT | |
| SCHEMBL60874 | 0.68 | ALDH1A1 (0.61) | KDM4EALDH1A1HPGDGAASTAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160118603-A1 | Organic Electronic Device | NOVALED GMBH (DE) | 2016-04-28 | — | — | US | claimed |
| WO-2014195482-A2 | ORGANIC ELECTRONIC DEVICE | NOVALED GMBH (DE) | 2014-12-11 | — | — | WO | claimed |
| US-10879473-B2 | Organic electronic device | NOVALED GMBH (DE) | 2020-12-29 | — | — | US | disclosed |
| US-10879473-B2 | Organic electronic device | NOVALED GMBH (DE) | 2020-12-29 | — | — | US | disclosed |
| US-20160118603-A1 | Organic Electronic Device | NOVALED GMBH (DE) | 2016-04-28 | — | — | US | disclosed |
| US-20160118603-A1 | Organic Electronic Device | NOVALED GMBH (DE) | 2016-04-28 | — | — | US | disclosed |
| US-20160118603-A1 | Organic Electronic Device | NOVALED GMBH (DE) | 2016-04-28 | — | — | US | disclosed |
| WO-2014195482-A2 | ORGANIC ELECTRONIC DEVICE | NOVALED GMBH (DE) | 2014-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10879473-B2 | Organic electronic device | OR10J3, LAGE3, L1CAM | KDM4E 1309/4885ALDH1A1 886/4885HPGD 3773/4885 |
| US-20160118603-A1 | Organic Electronic Device | OR10J3, LAGE3, L1CAM | KDM4E 1309/4885ALDH1A1 886/4885HPGD 3773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.